Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 and up

Comparing pain management methods for kidney surgery

Official title: Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy: Prospective Randomized Controlled Trial

Run by University Hospital of Split · NCT06595329 · Data updated 2026-11-12

This study is testing which pain management method, either an epidural or an intrathecal opioid, works better for people having kidney surgery to help them recover more comfortably.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity Hospital of Split
Academic / other
Locations1 site (Split)
StatusRecruiting
StartedJanuary 15, 2025
Main results expectedOctober 15, 2025
Study endsDecember 31, 2025
Registry record updatedMarch 10, 2025
Trial IDNCT06595329 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult patients over 18 years old scheduled for open radical or partial nephrectomy due to renal cell carcinoma.

Probably not a fit

Patients with severe comorbidities, contraindications to the interventions, or those unable to communicate preoperatively may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare two pain management techniques, epidural analgesia and intrathecal opioid analgesia, in patients undergoing open radical or partial nephrectomy for renal cancer. It is a prospective, single-center, randomized controlled trial conducted at the University Hospital of Split. The study will monitor various parameters, including acute pain levels, side effects, and the consumption of systemic analgesics during the first 72 hours post-surgery. The goal is to determine which method provides better pain relief and overall recovery outcomes for patients.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing major kidney surgeries.

How similar studies have gone: Previous studies have shown varying success with similar pain management approaches, but this specific comparison is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients over the age of 18, scheduled for an open radical or partial nephrectomy due to RCC.
* American Society of Anesthesiologists (ASA) physical status classification I-III.

Exclusion Criteria:

* Patients who refuse to participate in this study.
* Patients with BMI \> 35 kg/m2 or \< 15 kg/m2.
* Patients with renal dysfunction (eGFR \<15 or requirement of renal replacement therapy), liver dysfunction (Child-Pugh class C), and heart failure (NYHA IV).
* Patients with ASA physical status classification ≥ IV.
* Patients with contraindication for the interventions planned for in this study (allergies to anesthetic drugs used in this study, coagulation disorders, and infection at the injection site).
* Patients with chronic opioid dependence.
* Patients unable to communicate preoperatively due to severe dementia, language barrier, or neuropsychiatric disorder.
* Patients for whom it is impossible to carry out the aforementioned interventions for technical reasons.

Where it's running

  • Univeristy Hospital of Split
    Split, Croatia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Irreversible Electroporation for Recurrent Pelvic Tumors

    This study tests whether using irreversible electroporation (IRE) is safe and helps control recurrent pelvic tumors in adults who can’t have other local treatments.

    Recruiting Amsterdam UMC, location VUmc · Amsterdam, North Holland · NCT07782164

  • Registry of Minimally Invasive Cancer Treatments Using Spectral Angio-CT Guidance

    This registry collects data from adults undergoing image-guided, minimally invasive cancer treatments to see if spectral angio-CT guidance helps predict outcomes and improve planning.

    Recruiting Leiden University Medical Center · Lyon, Auvergne-Rhône-Alpes and 2 other locations · NCT07636148

  • How dexamethasone affects blood sugar during and after non-cardiac surgery

    We will see if a standard dose of dexamethasone raises blood sugar in adults having elective non-cardiac surgery and whether continuous glucose monitors detect changes better than finger-prick tests.

    Recruiting Zealand University Hospital · Roskilde · NCT07573930

  • Hospital admissions for blood in the urine

    This international observational project will look at how hospitals manage adults admitted with blood in the urine to see which approaches lead to shorter stays and better outcomes.

    Recruiting British Urology Researchers in Surgical Training · London · NCT07395037

  • SL-28 for Advanced Solid Tumours

    A new allogeneic cell therapy called SL-28 is being tested in adults with advanced solid tumors to see if it is safe and can help shrink tumors.

    Recruiting Phase 1/2 Second Life Therapeutics · Sydney, New South Wales and 2 other locations · NCT07341737

  • Spectral CT during embolization and ablation for liver and kidney tumors

    This pilot tries a new spectral CT technique during image-guided embolization and ablation for adults with liver or kidney tumors to see if it improves image quality and helps guide treatment.

    Recruiting Palo Alto Veterans Institute for Research · Palo Alto, California · NCT07303725

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.